Rottinghaus Scott T.

Chief Medical OfficerENANTA PHARMACEUTICALS INC (ENTA) · full profile →Form 4 · filed Jul 15, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$191K
Net Open-Market Flow
-$191K
Transactions
5
4 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 15, 2024Sell(S)5K$17.08$92K22K
Jul 15, 2024Option exercise(M)5K$8.99$48K27K
Jul 12, 2024Sell(S)2K$15.04$34K22K
Jul 11, 2024Sell(S)4K$15.07$65K24K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jul 15, 2024Option exercise(M)5K$081K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001062993-24-013820) within minutes of acceptance. Every field above traces to the original document. Verify it directly: